3
RNTX
AILERON THERAPEUTICS INC
- Report period
- 15 Jun 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 17 Jun 2022, 17:12
- Role
- Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney
- Next action
- Open filing details